(Q41019245)

25 September 2017

title

De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation (English)

1 reference

25 September 2017

1 reference

Martina Koch

1

1 reference

25 September 2017

Thorsten Wiech

2

1 reference

25 September 2017

Matthias Marget

3

1 reference

25 September 2017

Sven Peine

4

1 reference

25 September 2017

Hansjörg Thude

5

1 reference

25 September 2017

Eike G Achilles

6

1 reference

25 September 2017

Lutz Fischer

7

1 reference

25 September 2017

Anja Lehnhardt

8

1 reference

25 September 2017

Friedrich Thaiss

9

1 reference

25 September 2017

Bjoern Nashan

10

1 reference

25 September 2017

publication date

3 September 2015

1 reference

25 September 2017

published in

Clinical Transplantation

1 reference

25 September 2017

volume

29

1 reference

25 September 2017

issue

11

1 reference

25 September 2017

page(s)

1021-1028

1 reference

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab

25 September 2017

cites work

1 reference

Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.

21 January 2018

1 reference

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin

21 January 2018

1 reference

The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival

21 January 2018

1 reference

The influence of immunosuppression on the development of BK virus nephropathy-- does it matter?

21 January 2018

1 reference

BK virus nephropathy and kidney transplantation

21 January 2018

1 reference

Polyomavirus in renal transplantation: a hot problem.

21 January 2018

1 reference

Cytomegalovirus and polyomavirus BK posttransplant

21 January 2018

1 reference

Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients

21 January 2018

1 reference

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients

21 January 2018

1 reference

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

21 January 2018

1 reference

Early clinical experience with a novel rapamycin derivative

21 January 2018

1 reference

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions

21 January 2018

1 reference

Japanese experience of ABO-incompatible living kidney transplantation

21 January 2018

1 reference

ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies

21 January 2018

1 reference

Risk factors for polyoma virus nephropathy

21 January 2018

1 reference

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study

21 January 2018

1 reference

Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

21 January 2018

1 reference

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

21 January 2018

1 reference

Thrombotic microangiopathy after kidney transplantation

21 January 2018

1 reference

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

21 January 2018

1 reference

Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.

21 January 2018

1 reference

Renal transplant wound complications in the modern era of obesity

21 January 2018

1 reference

The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients

21 January 2018

1 reference

Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature

21 January 2018

1 reference

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

21 January 2018

1 reference

ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CTR.12624

1 reference

25 September 2017

1 reference